Cargando…
A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection
INTRODUCTION: Bovine respiratory syncytial virus (RSV) is a valid model for human RSV and an important bovine pathogen. Very early administration of ibuprofen and GS-561937, a fusion protein inhibitor (FPI), have separately been shown to decrease the severity of bovine RSV. Our aims were to determin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067438/ https://www.ncbi.nlm.nih.gov/pubmed/32163508 http://dx.doi.org/10.1371/journal.pone.0230245 |
_version_ | 1783505402662486016 |
---|---|
author | Walsh, Paul Lebedev, Maxim McEligot, Heather Mutua, Victoria Bang, Heejung Gershwin, Laurel J. |
author_facet | Walsh, Paul Lebedev, Maxim McEligot, Heather Mutua, Victoria Bang, Heejung Gershwin, Laurel J. |
author_sort | Walsh, Paul |
collection | PubMed |
description | INTRODUCTION: Bovine respiratory syncytial virus (RSV) is a valid model for human RSV and an important bovine pathogen. Very early administration of ibuprofen and GS-561937, a fusion protein inhibitor (FPI), have separately been shown to decrease the severity of bovine RSV. Our aims were to determine how long after RSV inoculation ibuprofen and GS-561937 can be administered with clinical benefit and whether using both was better than monotherapy. MATERIALS AND METHODS: We conducted a blinded randomized placebo controlled trial of ibuprofen, GS-561937 (FPI), or combinations of the two initiated at 3 or 5 days after artificial infection with bovine RSV in 36 five to six-week-old Holstein calves (Bos taurus). We measured clinical scores, respiratory rate, and viral shedding daily for 10 days following inoculation. We estimated the average effect for each drug and compared treatment arms using mixed effects models. RESULTS: We found a significant decrease in clinical scores only in the combined treatment arms. This benefit was greater when treatment was initiated at 3 days rather than 5 days post infection with decreased clinical scores and lower respiratory rates at both time points. Ibuprofen alone started on day 3 increased, and FPI with ibuprofen started on day 3 decreased, viral shedding. CONCLUSION: Dual therapy with Ibuprofen and FPI, on average, decrease clinical severity of illness in a bovine model of RSV when started at 3 and 5 days after infection. |
format | Online Article Text |
id | pubmed-7067438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-70674382020-03-23 A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection Walsh, Paul Lebedev, Maxim McEligot, Heather Mutua, Victoria Bang, Heejung Gershwin, Laurel J. PLoS One Research Article INTRODUCTION: Bovine respiratory syncytial virus (RSV) is a valid model for human RSV and an important bovine pathogen. Very early administration of ibuprofen and GS-561937, a fusion protein inhibitor (FPI), have separately been shown to decrease the severity of bovine RSV. Our aims were to determine how long after RSV inoculation ibuprofen and GS-561937 can be administered with clinical benefit and whether using both was better than monotherapy. MATERIALS AND METHODS: We conducted a blinded randomized placebo controlled trial of ibuprofen, GS-561937 (FPI), or combinations of the two initiated at 3 or 5 days after artificial infection with bovine RSV in 36 five to six-week-old Holstein calves (Bos taurus). We measured clinical scores, respiratory rate, and viral shedding daily for 10 days following inoculation. We estimated the average effect for each drug and compared treatment arms using mixed effects models. RESULTS: We found a significant decrease in clinical scores only in the combined treatment arms. This benefit was greater when treatment was initiated at 3 days rather than 5 days post infection with decreased clinical scores and lower respiratory rates at both time points. Ibuprofen alone started on day 3 increased, and FPI with ibuprofen started on day 3 decreased, viral shedding. CONCLUSION: Dual therapy with Ibuprofen and FPI, on average, decrease clinical severity of illness in a bovine model of RSV when started at 3 and 5 days after infection. Public Library of Science 2020-03-12 /pmc/articles/PMC7067438/ /pubmed/32163508 http://dx.doi.org/10.1371/journal.pone.0230245 Text en © 2020 Walsh et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Walsh, Paul Lebedev, Maxim McEligot, Heather Mutua, Victoria Bang, Heejung Gershwin, Laurel J. A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection |
title | A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection |
title_full | A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection |
title_fullStr | A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection |
title_full_unstemmed | A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection |
title_short | A randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection |
title_sort | randomized controlled trial of a combination of antiviral and nonsteroidal anti-inflammatory treatment in a bovine model of respiratory syncytial virus infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067438/ https://www.ncbi.nlm.nih.gov/pubmed/32163508 http://dx.doi.org/10.1371/journal.pone.0230245 |
work_keys_str_mv | AT walshpaul arandomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT lebedevmaxim arandomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT mceligotheather arandomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT mutuavictoria arandomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT bangheejung arandomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT gershwinlaurelj arandomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT walshpaul randomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT lebedevmaxim randomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT mceligotheather randomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT mutuavictoria randomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT bangheejung randomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection AT gershwinlaurelj randomizedcontrolledtrialofacombinationofantiviralandnonsteroidalantiinflammatorytreatmentinabovinemodelofrespiratorysyncytialvirusinfection |